UNSPSC 41202021: Enterovirus nucleic acid assay

In this classification, Enterovirus nucleic acid assay are devices used in test to identify specific Enterovirus nucleic acid assay antibodies in serum. US FDA regulates Enterovirus nucleic acid assay under 21 CFR 866.3225 and under FDA product code OAI.

UNSPSC 41202021 Enterovirus nucleic acid assay is a Commodity code capturing diagnostic laboratory testing supplies and services for nucleic acid detection. State and local health departments and criminal justice agencies are actively procuring nucleic acid testing kits, reagents, and related laboratory services under this code and adjacent clinical diagnostics classifications. Recent solicitations show agencies purchasing rapid diagnostic test kits (HIV, syphilis, sexually transmitted infections), specimen collection and testing services, drug screening supplies compatible with automated analyzers, and comprehensive laboratory testing platforms. The issuing bodies include state health departments (Illinois Department of Public Health, Texas Department of Criminal Justice), county health and criminal justice agencies (Collin County Health Care Services, Collin County Community Supervision and Corrections Department, Gwinnett County), and municipal public health programs (City of Austin). Illinois Department of Public Health and Collin County appear as repeat buyers in the recent record.

Activity concentrates in Texas and Illinois, with ancillary procurement in Georgia and Arizona. Representative recent opportunities include the Illinois Department of Public Health's change order (September 2026) for 25,000 annual Hologic NG/NT testing units and 30,000 collection kits to meet statewide sexually transmitted infection screening demand under a five-year contract valued at $900,000; Collin County Community Supervision and Corrections Department's RFP (September 2026) for offender specimen collection and drug testing services at approximately 25,031 annual tests with an estimated contract value of $600,000; the City of Austin's IFB (August 2026, rebid) for Abbott Determine HIV 1/2 test kits and controls at 375 kits and 79 control kits annually; and Gwinnett County's RFP (September 2026) for drug testing supplies compatible with an existing drugs of abuse analyzer system. The Illinois Department of Public Health also conducted emergency sole-source procurements for HIV and syphilis reagents and maintenance services from Abbott Laboratories in May 2026 valued at $38,079.50.